Aetion raises $36m, Carolyn Magill interview

BY MATTHEW HOLT It’s not every day that an analytics firm focusing on improving the efficacy and value of drugs has a big raise in the health tech world–especially one I don’t know much about. This morning Aetion raised $36m to add onto $11m they raised last year. Their new round is led by famed venture firm NEA and includes Amgen Ventures. I spoke to CEO and part-time extreme skier Carolyn Magill to find out what Aetion does and why big pharma and major payers need their help in the brave new world of value-based care.
Source: The Health Care Blog - Category: Consumer Health News Authors: Tags: Matthew Holt The Business of Health Care Value-Based Care Aetion Amgen ventures Carolyn Magill Source Type: blogs